These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 11507078)

  • 61. TGF-beta-1 up-regulates cyclin D1 expression in COLO-357 cells, whereas suppression of cyclin D1 levels is associated with down-regulation of the type I TGF-beta receptor.
    Kornmann M; Tangvoranuntakul P; Korc M
    Int J Cancer; 1999 Oct; 83(2):247-54. PubMed ID: 10471535
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Transactivation of the human NME5 gene by Sp1 in pancreatic cancer cells.
    Li F; Jiang Z; Wang K; Guo J; Hu G; Sun L; Wang T; Tang X; He L; Yao J; Wen D; Qin X; Zhang L
    Gene; 2012 Jul; 503(2):200-7. PubMed ID: 22564704
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Acetylated sp3 is a transcriptional activator.
    Ammanamanchi S; Freeman JW; Brattain MG
    J Biol Chem; 2003 Sep; 278(37):35775-80. PubMed ID: 12837748
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Regulation of the transforming growth factor-beta 1 and -beta 3 promoters by transcription factor Sp1.
    Geiser AG; Busam KJ; Kim SJ; Lafyatis R; O'Reilly MA; Webbink R; Roberts AB; Sporn MB
    Gene; 1993 Jul; 129(2):223-8. PubMed ID: 8325508
    [TBL] [Abstract][Full Text] [Related]  

  • 65. PROX1 overexpression inhibits protein kinase C beta II transcription through promoter DNA methylation.
    Hagiwara K; Ito H; Murate T; Miyata Y; Ohashi H; Nagai H
    Genes Chromosomes Cancer; 2012 Nov; 51(11):1024-36. PubMed ID: 22833470
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Distinct roles of transforming growth factor-β signaling and transforming growth factor-β receptor inhibitor SB431542 in the regulation of p21 expression.
    Koo BH; Kim Y; Je Cho Y; Kim DS
    Eur J Pharmacol; 2015 Oct; 764():413-423. PubMed ID: 26187313
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Alteration of cell growth and morphology by overexpression of transforming growth factor beta type II receptor in human lung adenocarcinoma cells.
    Kim TK; Mo EK; Yoo CG; Lee CT; Han SK; Shim YS; Kim YW
    Lung Cancer; 2001; 31(2-3):181-91. PubMed ID: 11165397
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells.
    Wang J; Han W; Zborowska E; Liang J; Wang X; Willson JK; Sun L; Brattain MG
    J Biol Chem; 1996 Jul; 271(29):17366-71. PubMed ID: 8663343
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Increased transcriptional activities of transforming growth factor beta receptors in scleroderma fibroblasts.
    Yamane K; Ihn H; Kubo M; Tamaki K
    Arthritis Rheum; 2002 Sep; 46(9):2421-8. PubMed ID: 12355490
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Expression of and response to growth regulatory peptides by two human pancreatic carcinoma cell lines.
    Beauchamp RD; Lyons RM; Yang EY; Coffey RJ; Moses HL
    Pancreas; 1990 Jul; 5(4):369-80. PubMed ID: 2199964
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Elevated Egr-1 in human atherosclerotic cells transcriptionally represses the transforming growth factor-beta type II receptor.
    Du B; Fu C; Kent KC; Bush H; Schulick AH; Kreiger K; Collins T; McCaffrey TA
    J Biol Chem; 2000 Dec; 275(50):39039-47. PubMed ID: 10982796
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Correlation between suppression of c-myc and antiproliferative effect of transforming growth factor-beta 1 in thyroid carcinoma cell growth.
    Usa T; Tsukazaki T; Namba H; Ohtsuru A; Kimura H; Villadolid MC; Nagataki S; Yamashita S
    Endocrinology; 1994 Oct; 135(4):1378-84. PubMed ID: 7925100
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Induction of Ley antigen by 5-aza-2'-deoxycytidine in association with differentiation and apoptosis in human pancreatic cancer cells.
    Yamada T; Ohwada S; Saitoh F; Adachi M; Morishita Y; Hozumi M
    Anticancer Res; 1996; 16(2):735-40. PubMed ID: 8687122
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Soluble type II transforming growth factor-beta receptor attenuates expression of metastasis-associated genes and suppresses pancreatic cancer cell metastasis.
    Rowland-Goldsmith MA; Maruyama H; Matsuda K; Idezawa T; Ralli M; Ralli S; Korc M
    Mol Cancer Ther; 2002 Jan; 1(3):161-7. PubMed ID: 12467210
    [TBL] [Abstract][Full Text] [Related]  

  • 75. 5-Azacytidine treatment of HA-A melanoma cells induces Sp1 activity and concomitant transforming growth factor alpha expression.
    Shin TH; Paterson AJ; Grant JH; Meluch AA; Kudlow JE
    Mol Cell Biol; 1992 Sep; 12(9):3998-4006. PubMed ID: 1380648
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mechanism of E1A-induced transforming growth factor-beta (TGF-beta) resistance in mouse keratinocytes involves repression of TGF-beta type II receptor transcription.
    Kim DH; Chang JH; Lee KH; Lee HY; Kim SJ
    J Biol Chem; 1997 Jan; 272(1):688-94. PubMed ID: 8995313
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Resistance to TGF-beta 1 correlates with aberrant expression of TGF-beta receptor II in human B-cell lymphoma cell lines.
    Chen G; Ghosh P; Osawa H; Sasaki CY; Rezanka L; Yang J; O'Farrell TJ; Longo DL
    Blood; 2007 Jun; 109(12):5301-7. PubMed ID: 17339425
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Epigenetic regulation of KLK7 gene expression in pancreatic and cervical cancer cells.
    Raju I; Kaushal GP; Haun RS
    Biol Chem; 2016 Nov; 397(11):1135-1146. PubMed ID: 27279059
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Relation of type II transforming growth factor-beta receptor to hepatic fibrosis and hepatocellular carcinoma.
    Ueno T; Hashimoto O; Kimura R; Torimura T; Kawaguchi T; Nakamura T; Sakata R; Koga H; Sata M
    Int J Oncol; 2001 Jan; 18(1):49-55. PubMed ID: 11115538
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Decitabine represses translocated MYC oncogene in Burkitt lymphoma.
    Guan H; Xie L; Klapproth K; Weitzer CD; Wirth T; Ushmorov A
    J Pathol; 2013 Apr; 229(5):775-83. PubMed ID: 23341364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.